Richard A. Flavell,Nicola Gagliani,Silvia Gregori,Samuel Huber,Chiara Francesca Magnani,Maria Grazia Roncarolo
申请号：
US14407627
公开号：
US20150132272A1
申请日:
2013.06.18
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purity and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders.
